Answers are grounded in this paper and cite their sources.
Formation of type I collagen from procollagen causes release of propeptides which can be detected in serum. Measurement of the procollagen carboxy-terminal pro peptide (PICP) by radioimmunoassay has shown that serum levels correlate with the rate of bone formation, and increased concentrations have been reported in skeletal growth, Paget's disease and bone metastases.l? The carboxy-terminal telopeptide of type I collagen (ICTP) is released on collagen degradation and has been quantitated in serum by radioimmunoassay as a putative marker of bone resorption ..1 Significant increases in ICTP levels have been found in patients with skeletal growth, rheumatoid arthritis, metastatic bone lesions or renal impairment. Although the extent of normal physiological variation in serum PICP and ICTP within individuals is not clear, significant changes in PICP and/or ICTP levels have been observed in response to various treatments. The result of any biochemical analysis is generally reported as a single value which is an estimate of the homeostatic set-point, and has an associated variance, the intra-individual variance, with analytical and biological components. A reference interval may be determined using samples from normal individuals but, when the intra-individual variance is lower than the inter-individual variance, serial comparison of values within an individual may be more useful than comparison with a reference interval. Since serum levels of PICP and ICTP may be genetically determined, the expected high between-subject variance may cause comparison with reference intervals to be a poor guide to the rate of bone turnover in any individual. The use of these markers in monitoring levels over time
No takes yet. Share an insight, caveat, or question.
Stevenson et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: